176
Views
5
CrossRef citations to date
0
Altmetric
Original Article

IL-6 is an independent predictive factor of drug survival after dose escalation of infliximab in patients with rheumatoid arthritis

, , , , &
Pages 452-460 | Received 10 Mar 2017, Accepted 15 Jul 2017, Published online: 22 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jean-Guillaume Letarouilly, Jean-Hugues Salmon & René-Marc Flipo. (2021) Factors affecting persistence with biologic treatments in patients with rheumatoid arthritis: a systematic literature review. Expert Opinion on Drug Safety 20:9, pages 1087-1094.
Read now

Articles from other publishers (4)

Sho Masui, Atsushi Yonezawa, Miyuki Nakamura, Akira Onishi, Motomu Hashimoto, Hideo Onizawa, Takayuki Fujii, Kosaku Murakami, Koichi Murata, Masao Tanaka, Kotoko Yokoyama, Noriko Iwamoto, Takashi Shimada, Kotaro Itohara, Daiki Hira, Shunsaku Nakagawa, Satoshi Imai, Takayuki Nakagawa, Makoto Hayakari, Shuichi Matsuda, Akio Morinobu, Tomohiro Terada & Kazuo Matsubara. (2023) Serum Concentrations of Infliximab and IL-6 for Predicting One-Year Discontinuation of Infliximab Treatment Owing to Secondary Non-response in Patients with Rheumatoid Arthritis. Biological and Pharmaceutical Bulletin 46:8, pages 1112-1119.
Crossref
K. Kornicka-Garbowska, S. Groborz, B. Lynda, L. Galuppo & K. Marycz. (2022) Mitochondria transfer restores fibroblasts-like synoviocytes (FLS) plasticity in LPS-induced, in vitro synovitis model. Cell Communication and Signaling 20:1.
Crossref
V. V. Rybakova, A. S. Avdeeva, D. A. Dibrov & Е. L. Nasonov. (2022) Relationship of cytokine level dynamics with longterm results of early rheumatoid arthritis therapy. Rheumatology Science and Practice 60:1, pages 72-79.
Crossref
Jie Yang, Junhu Wang, Xiaojun Liang, Hongmou Zhao, Jun Lu, Qiang Ma, Bingfei Jing & Feng Tian. (2019) IL‑1β increases the expression of inflammatory factors in synovial fluid‑derived fibroblast‑like synoviocytes via activation of the NF‑κB‑mediated ERK‑STAT1 signaling pathway. Molecular Medicine Reports.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.